Enhanced functional recovery from spinal cord injury following intrathecal or intramuscular administration of poliovirus replicons encoding IL-10

Virology

Volumn 336, Issue 2, 2005, Pages 173-183

  Jackson, Cheryl A ^a   Messinger, Jeffery ^a   Peduzzi, Jean D ^b   Ansardi, David C ^a   Morrow, Casey D ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

IL 10; Poliovirus replicons; Spinal cord injury

Indexed keywords

INTERLEUKIN 10; VIRUS RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL COMPOSITION; CONTROLLED STUDY; GENE DELIVERY SYSTEM; GENE TARGETING; GENETIC CODE; HUMAN; HUMAN CELL; INOCULATION; MICROGLIA; MOTONEURON; MOUSE; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; SPINAL CORD INJURY; TISSUE CULTURE;

ANIMALS; ASTROCYTES; DISEASE MODELS, ANIMAL; GENETIC VECTORS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SPINAL; INTERLEUKIN-10; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; POLIOVIRUS; RECEPTORS, VIRUS; REPLICON; SPINAL CORD; SPINAL CORD INJURIES; TIME FACTORS;

ANIMALIA; POLIOVIRUS;

EID: 18844388740     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.03.025     Document Type: Article

References (31)

1. K.E. Abraham, D. McMillen, and K.L. Brewer The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse Neuroscience 124 4 2004 945 952
2. D.C. Ansardi, D.C. Porter, C.A. Jackson, G.Y. Gillespie, and C.D. Morrow RNA replicons derived from poliovirus are directly oncolytic for human tumor cells of diverse origins Cancer Res. 61 2001 8470 8479
3. A. Bachis, A.M. Colangelo, S. Vicini, P.P. Doe, M.A. De Bernardi, G. Brooker, and I. Mocchetti Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity J. Neurosci. 21 9 2001 3104 3112
4. V. Balasingam, and V.W. Yong Attenuation of astroglial reactivity by interleukin-10 J. Neurosci. 16 9 1996 2945 2955
5. J.R. Bethea, H. Nagashima, M.C. Acosta, C. Briceno, F. Gomez, A.E. Marcillo, K. Loor, J. Green, and W.D. Dietrich Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats J. Neurotrauma 16 1999 851 863
6. A.W. Bledsoe, G.Y. Gillespie, and C.D. Morrow Targeted foreign gene expression in spinal cord neurons using poliovirus replicons J. NeuroVirol. 6 2000 95 105
7. A.W. Bledsoe, C.A. Jackson, S. McPherson, and C.D. Morrow Cytokine production in motor neurons by poliovirus replicon vector gene delivery Nat. Biotechnol. 18 2000 964 969
8. D. Bodian Histopathological basis of clinical findings in poliomyelitis Am. J. Med. 6 1949 563 578
9. D. Bodian, and H.A. Howe Emerging concept of poliomyelitis infection Science 122 1955 105 108
10. C. Brodie Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytes FEBS Lett. 394 1996 117 120
11. G.M. Crisi, L. Santambrogio, G.M. Hochwald, S.R. Smith, J.A. Carlino, and G.J. Thorbecke Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10 Eur. J. Immunol. 25 1995 3035 3040
12. A.M. Deatly, R.E. Taffs, J.M. McAuliffe, S.P. Nawoschik, J.W. Coleman, G. McMullen, C. Weeks-Levy, A.J. Johnson, and V.R. Racaniello Characterization of mouse lines transgenic with the human poliovirus receptor gene Microb. Pathog. 25 1 1998 43 54
13. A.M. Deatly, J.W. Coleman, G. McMullen, J.M. McAuliffe, V. Jayarama, A. Cupo, J.C. Crowley, T. McWilliams, and R.E. Taffs Poliomyelitis in intraspinally inoculated poliovirus receptor transgenic mice Virology 255 1999 221 227
14. D.F. Fiorentino, A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra IL-10 inhibits cytokine production by activated macrophages J. Immunol. 147 11 1991 3815 3822
15. M. Grilli, I. Barbieri, H. Basudev, R. Brusa, C. Casati, G. Lozza, and E. Ongini Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage Eur. J. Neurosci. 12 2000 2265 2272
16. S. Hulfshof, L. Montagne, C.J.A. de Groot, and P. van der Valk Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions Glia 38 2002 24 35
17. C.A. Jackson, C. Cobbs, J.D. Peduzzi, M. Novak, and C.D. Morrow Repetitive intrathecal injections of poliovirus replicons result in gene expression in neurons of the central nervous system without pathogenesis Hum. Gene Ther. 12 2001 1827 1841
18. C.A. Jackson, J. Messinger, M. Palmer, J. Peduzzi, and C.D. Morrow Gene expression in the muscle and central nervous system following intramuscular inoculation of encapsidated or naked poliovirus replicons results Virology 314 1 2003 45 61
19. A.J. Kastin, V. Akerstrom, and W. Pan Interleukin-10 as a CNS therapeutic: the obstacle of the blood-brain/blood-spinal cord barrier Mol. Brain Res. 114 2003 168 171
20. P.L. Kuhn, and J.R. Wrathall A mouse model of graded contusive spinal cord injury J. Neurotrauma 15 1998 125 140
21. M.J. Novak, Z. Moldoveanu, W.Q. Huang, C.A. Jackson, M.T. Palmer, S.A. McPherson, and C.D. Morrow Intramuscular immunization with poliovirus replicons primes for a humor and cellular immune response to soluble antigen Viral Immunol. 16 2 2003 169 182
22. D.D. Pearse, A.E. Marcillo, M. Oudega, M.P. Lynch, P.M. Wood, and M.B. Bunge Transplantation of Schwann cells and olfactory ensheathing glia after spinal cord injury: does pretreatment with methylprednisolone and interleukin-10 enhance recovery? J. Neurotrauma 21 9 2004 1223 1239
23. J.A. Plunkett, C.-G. Yu, J.M. Easton, J.R. Bethea, and R.P. Yezierski Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat Exp. Neurol. 168 2001 144 154
24. D.C. Porter, D.C. Ansardi, and C.D. Morrow Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans J. Virol. 69 1995 1548 1555
25. D.C. Porter, L.R. Melsen, R.W. Compans, and C.D. Morrow Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag J. Virol. 70 1996 2643 2649
26. D.C. Porter, J. Wang, Z. Moldoveanu, S. McPherson, and C.D. Morrow Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin Vaccine 15 1997 257 264
27. D.C. Porter, D.C. Ansardi, J. Wang, S. McPherson, Z. Moldoveanu, and C.D. Morrow Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferase Virology 243 1998 1 11
28. R. Ren, and V.R. Racaniello Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice J. Virol. 66 1992 296 304
29. R. Ren, and V.R. Racaniello Poliovirus spreads from muscle to the central nervous system by neural pathways J. Infect. Dis. 166 1992 747 752
30. A.S. Rivlin, and C.H. Tator Objective clinical assessment of motor function after experimental spinal cord injury in the rat J. Neurosurg. 47 1977 577 581
31. T. Takami, M. Oudega, J.R. Bethea, P.M. Wood, N. Kleitman, and M.B. Bunge Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome J. Neurotrauma 19 5 2002 653 666